Related Experiment Video
Updated: Jul 7, 2026
09:49
Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
Published on: June 29, 2022
Effects interferon-2alpha on seizures in corasol-induced kindling
V I Kresyun1, E V Kobolev, I V Smirnov
1Odessa State Medical University, Ukraine.
Bulletin of Experimental Biology and Medicine
|February 8, 2008
Summary
Recombinant human interferon-2alpha (IFN-2α) reduced the dose of corasol needed to induce seizures in kindled rats. This effect was stronger during later stages of kindling and worsened EEG seizure signs.
Area of Science:
- Neuroscience
- Pharmacology
- Immunology
Background:
- Epilepsy is a neurological disorder characterized by recurrent seizures.
- Interferons are signaling proteins with diverse biological functions.
- Kindling is a model used to study the development of epilepsy.
Purpose of the Study:
- To investigate the effect of recombinant human interferon-2alpha (IFN-2α) on seizure susceptibility in a kindled rat model.
- To determine if IFN-2α influences the development or expression of kindled epilepsy.
Main Methods:
- Intracerebroventricular injections of IFN-2α (100-500 U/rat) were administered to kindled Wistar rats.
- Seizure susceptibility was assessed by determining the mean effective dose of corasol required to induce clonic convulsions.
- Electroencephalogram (EEG) was used to monitor epileptiform activity.
Main Results:
- IFN-2α administration significantly decreased the mean effective dose of corasol needed to induce seizures.
- This anticonvulsant effect was more pronounced during delayed periods of kindling.
- EEG recordings showed an enhancement of epileptiform signs following IFN-2α treatment.
Conclusions:
- Recombinant human IFN-2α exhibits anticonvulsant properties in a kindled rat model.
- IFN-2α may modulate seizure threshold and epileptiform activity.
- Further research is warranted to explore the therapeutic potential of interferons in epilepsy.
Related Concept Videos
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:19Seizures ll: Types
Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...